MHH scientists improve three variants of the CRISPR-Cas9 system for more targeted and effective biomedical application.
CRISPR-edited insulin cells restore natural insulin in a Type 1 diabetes patient without rejection or immunosuppressants, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback